Skip to main content
Joshua Zeidner, MD

January 14, 2020

Phase I study indicates drug could boost immune function in blood cancers

An early-stage clinical study investigating a method of boosting the body’s defenses against two blood cancers found the drug pomalidomide could be safely added to conventional treatments, and help improve immune function. University of North Carolina Lineberger Comprehensive Cancer Center researcher Joshua Zeidner, MD, assistant professor in the UNC School of Medicine Division of Hematology/Oncology, …